Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAmicus Therapeutics Inc Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | $0.05 | $0.05 | $0.05 |
| Q2 2026 | 1 | $0.09 | $0.09 | $0.09 |
| Q3 2026 | 1 | $0.11 | $0.11 | $0.11 |
| Q4 2026 | 1 | $0.12 | $0.12 | $0.12 |
| Q1 2027 | 1 | $0.10 | $0.10 | $0.10 |
| Q2 2027 | 1 | $0.13 | $0.13 | $0.13 |
| Q3 2027 | 1 | $0.18 | $0.18 | $0.18 |
| Q4 2027 | 1 | $0.42 | $0.44 | $0.43 |
Amicus Therapeutics Inc Earnings Date And Information
Amicus Therapeutics Inc last posted its earnings results on Friday, February 20th, 2026. The company reported $0.01 earnings per share for the quarter, missing analysts' consensus estimates of $0.07143 by $0.06143. The company had revenue of 185.21 M for the quarter and had revenue of 634.21 M for the year. Amicus Therapeutics Inc has generated $0 earnings per share over the last year ($-0.0879 diluted earnings per share) and currently has a price-to-earnings ratio of -165.17. Amicus Therapeutics Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Amicus Therapeutics Inc Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/20/2026 | Q4 2025 | $0.07 | $0.01 | -0.07 | $180.53 M | $185.21 M |
| 11/04/2025 | Q3 2025 | $0.12 | $0.06 | -0.06 | $165.71 M | $169.06 M |
| 07/31/2025 | Q2 2025 | $0.02 | -$0.08 | -0.1 | $146.67 M | $154.69 M |
| 05/01/2025 | Q1 2025 | $0.08 | -$0.07 | -0.15 | $135.87 M | $125.25 M |
| 02/19/2025 | Q4 2024 | $0.02 | $0.05 | 0.03 | $147.87 M | $149.71 M |
| 11/06/2024 | Q3 2024 | $0.08 | -$0.02 | -0.1 | $134.93 M | $141.52 M |
| 08/08/2024 | Q2 2024 | $0.05 | -$0.05 | -0.1 | $121.21 M | $126.67 M |
| 05/09/2024 | Q1 2024 | -$0.06 | -$0.16 | -0.1 | $111.19 M | $110.40 M |
| 02/28/2024 | Q4 2023 | -$0.06 | -$0.12 | -0.06 | N/A | $115.08 M |
| 11/08/2023 | Q3 2023 | -$0.08 | -$0.07 | 0.01 | N/A | $103.50 M |
| 08/08/2023 | Q2 2023 | -$0.12 | -$0.15 | -0.03 | N/A | $94.50 M |
| 05/10/2023 | Q1 2023 | -$0.13 | -$0.18 | -0.05 | N/A | $86.27 M |
| 03/01/2023 | Q4 2022 | -$0.13 | -$0.20 | -0.07 | N/A | $88.10 M |
| 11/07/2022 | Q3 2022 | -$0.19 | -$0.12 | 0.07 | N/A | $81.69 M |
| 08/04/2022 | Q2 2022 | -$0.23 | -$0.21 | 0.02 | N/A | $80.73 M |
| 05/10/2022 | Q1 2022 | N/A | -$0.30 | N/A | N/A | $78.72 M |
| 02/24/2022 | Q4 2021 | -$0.14 | -$0.30 | -0.16 | N/A | $82.15 M |
| 11/09/2021 | Q3 2021 | -$0.18 | -$0.19 | -0.01 | N/A | $79.55 M |
| 08/05/2021 | Q2 2021 | -$0.21 | -$0.19 | 0.02 | N/A | $77.41 M |
| 05/10/2021 | Q1 2021 | -$0.23 | -$0.25 | -0.02 | N/A | $66.40 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Amicus Therapeutics Inc Earnings: FAQ's
The conference call for Amicus Therapeutics Inc's latest earnings report can be listened to online.
The conference call transcript for Amicus Therapeutics Inc's latest earnings report can be read online.
Amicus Therapeutics Inc (:FOLD) has a recorded annual revenue of $634.21 M.
Amicus Therapeutics Inc (:FOLD) has a recorded net income of $-27,110,000.Amicus Therapeutics Inc has generated $-0.0879 earnings per share over the last four quarters.
Amicus Therapeutics Inc (:FOLD) has a price-to-earnings ratio of -165.17 and price/earnings-to-growth ratio is 1.7.